Korean Market
EXCH
Abpro Bio
★

Abpro Bio Confirms Lock-up of 4.11M New Shares by Largest Shareholder, Reducing Near-Term Selling Pressure

 
OWNR
Abpro Bio
★

Abpro Bio, EGM Schedule Changed and Key Agenda Including Name Change and Par Value Adjustment Submitted... Limited Impact on Shareholder Value

 
OTHR
Abpro Bio
★★

Abpro Bio Renames to RootK, Reverse Stock Split, and New Provision for Third-Party Treasury Share Disposal Raises Dilution Risk

 
EXCH
Abpro Bio
★

Extraordinary General Meeting Date Rescheduled and Business Purpose Amendments Proposed... Two New Outside Director Candidates

 
EXCH
Abpro Bio
★

Abpro Bio Resolves Reverse Stock Split and Schedule Change: Aiming to Stabilize Stock Price via Per-Share Value Adjustment

 
OWNR
Abpro Bio
★

Par Value Change (500→1,000 KRW) Causing Reverse Stock Split, Name Change (Abpro Bio→RootK) and Major Business Purpose Revision

 
OTHR
Abpro Bio
★

Abpro Bio to change name to RootK and increase par value from 500 won to 1,000 won

 
EXCH
Abpro Bio
★

2026 Extraordinary General Meeting: Articles Amendment and Election of Outside Director & Audit Committee Member

 
EXCH
Abpro Bio
★

2:1 Stock Merger Decision, Outstanding Shares Halved

 
MATR
Abpro Bio
★

Correction of Remaining Convertible Bond Issuance Limit to 344.8 Billion Won (from 341.8 Billion)

 
PERI
Abpro Bio
★

Abpro Bio Improves Financial Structure via 10:1 Capital Reduction and Paid-in Capital Increase, Narrowing Q1 Operating Loss

 
EXCH
Abpro Bio
★

Completion of 19th Private Convertible Bond Issuance (2B KRW, Reduced from Initial 3B)

 
MATR
Abpro Bio
★

ABproBio Reduces Convertible Bond Issuance to KRW 2 Billion and Corrects Issuer Name

 
OWNR
Abpro Bio
★

Filing of Large Shareholding Report (No Specific Details)

 
OWNR
Abpro Bio
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders (No Change)